Orbimed Advisors LLC
Annual return '25
+14.8%
SPY '25
+17.7%
Alpha
-2.9ptsvs SPY
Invested
$5B
Holdings
111
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 60%. 2 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$EWTX
EDGEWISE THERAPEUTICS INC
Q1 2026: New position (5.6k shares)
9.7%
02
$ELVN
ENLIVEN THERAPEUTICS INC
Q1 2026: New position (3.4k shares)
6.2%
03
$MDXH
MDXHEALTH SA
Held since at least Q1 2024
5.7%
04
$LLY
ELI LILLY & CO
Q1 2026: New position (20.7k shares)
4.3%
05
$RCEL
AVITA MEDICAL INC
Q1 2026: New position (2.1k shares)
3.9%
06
$SVA
SINOVAC BIOTECH LTD
Q4 2024: New position (2.72M shares)
3.7%
07
$BSX
BOSTON SCIENTIFIC CORP
Q1 2026: New position (13.3k shares)
3.0%
08
$SION
SIONNA THERAPEUTICS INC
Q1 2026: New position (1.3k shares)
2.8%
09
$AZN
ASTRAZENECA PLC
Q3 2025: Increased +50.0% (100.0k → 150.0k shares)
2.6%
10
$MYGN
MYRIAD GENETICS INC
Q1 2026: New position (7.7k shares)
2.4%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:22 UTC.